Please register to access the Learning Network

The contents on this page can only be viewed by members of the Learning Network. If you're already a member, please take a moment to log in to the network. If not, please register.

This online Learning Network provides members with information and support around Quality Improvement (QI), an evidence-based approach that helps primary care free up time to deliver and evaluate initiatives, and embed new approaches more effectively and efficiently into practice.

QI helps us to make the most of our systems, organisations, talents and expertise to deliver better outcomes for patients.

Members have access to useful resources and case studies as well as opportunities to share learning from their experiences and make useful links with others interested in QI.

Whether you have been undertaking QI work for a while or just want to find out more, this network can support you in your journey and connect you to colleagues across the country who are working in innovative ways.

Membership is open to people working in GP practices and other organisations that support them. Register now to become a member of the Learning Network.

This network has been developed as part of the Royal College of General Practice’s Quality Improvement programme, led by two Clinical Lead’s Dr Mike Holmes and Dr Simon Stockill. If you have any questions about the programme please get in touch with the team at QI.Ready@rcgp.org.uk.

RCGP RSS News Feed

College welcomes continued research into widely used anti-depressants

She said: "It is well-established that it often takes a while for patients to feel the full benefits of modern antidepressants and that they work best when taken for significant periods of time, which is one reason why doctors will often review patients after several weeks of use and then prescribe a fairly long course of the drugs, if they appear to be beneficial.

"This study gives an interesting insight into how a medication primarily used to treat depression may be improving a patients' health in other ways in the shorter term, by reducing symptoms of anxiety, which is often associated with depression.

"It is always encouraging to see continued research into widely-used medications, and it is important that it is taken into account in the development of clinical guidelines so that GPs and other prescribers can continue to provide the best possible care for patients, based on the most up to date evidence.

"GPs will always aim to prescribe medication in the best interests of patients, in line with clinical guidelines, after assessing the needs of the individual, and taking into account any physical, psychological and social factors that might be affecting their health – including discussing any possible side effects and expected timescales.

"Patients should not be concerned about taking antidepressants as a result of this research, but if they are, they should continue to take them as prescribed and plan to discuss this with their doctor at their next routine appointment."